CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$1.29 USD
-0.07 (-4.81%)
Updated Jul 15, 2024 03:58 PM ET
After-Market: $1.29 +0.01 (0.39%) 7:38 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.29 USD
-0.07 (-4.81%)
Updated Jul 15, 2024 03:58 PM ET
After-Market: $1.29 +0.01 (0.39%) 7:38 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Zacks News
Why Seasoned Investors are Retaining Select Medical (SEM) Stock
by Zacks Equity Research
Select Medical (SEM) is focused on making strategic acquisitions to boost its business through inorganic growth.
Acadia (ACHC) & Orlando Health Form JV, Boosts Presence
by Zacks Equity Research
Acadia Healthcare Company (ACHC) expects to take on Orlando Health South Seminole Hospital's management responsibilities of the behavioral health program.
Why Seasoned Investors are Retaining Acadia (ACHC) Stock
by Zacks Equity Research
Acadia Healthcare's (ACHC) buyouts are helping the company to add facilities, beds and hospitals to its network and contributing to its top line.
Teladoc (TDOC) Falls 8.1% Despite Upbeat Revenue Guidance
by Zacks Equity Research
Teladoc Health (TDOC) expects revenues to rise to more than $4 billion in 2024.
Analysts Estimate CoDiagnostics, Inc. (CODX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CoDiagnostics, Inc. (CODX) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
CoDiagnostics, Inc. (CODX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 43.48% and 30.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CoDiagnostics, Inc. (CODX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in CoDiagnostics, Inc. (CODX): Can Its 9.7% Jump Turn into More Strength?
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Are Investors Undervaluing CoDiagnostics, Inc. (CODX) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Value Investor Highlights: Hibbett Sports, CoDiagnostics, Quidel Corp, DHT Holdings and Rocket Companies
by Zacks Equity Research
Zacks Value Investor Highlights: Hibbett Sports, CoDiagnostics, Quidel Corp, DHT Holdings and Rocket Companies
Screening for Ben Graham Value Stocks
by Tracey Ryniec
What kind of value stocks would Ben Graham, the father of value investing, be looking at in 2021?
CoDiagnostics, Inc. (CODX) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 30.00% and 2.69%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
CoDiagnostics, Inc. (CODX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CoDiagnostics, Inc. (CODX) Q4 Earnings Lag Estimates
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -12.24% and 1.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics (CODX) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Co-Diagnostics' (CODX) third-quarter results are likely to reflect higher COVID-19 test sales.
CoDiagnostics, Inc. (CODX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) closed the most recent trading day at $14.42, moving +0.07% from the previous trading session.
Implied Volatility Surging for Co-Diagnostics (CODX) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Co-Diagnostics (CODX) stock based on the movements in the options market lately.
Company News for Oct 5, 2020
by Zacks Equity Research
Companies in the news are: UBER, WMT, BBBY, CODX
CoDiagnostics, Inc. (CODX) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -29.51% and -10.96%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics (CODX) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Co-Diagnostics' (CODX) second-quarter results are likely to reflect higher COVID-19 test sales.
CoDiagnostics, Inc. (CODX) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CoDiagnostics, Inc. (CODX) closed at $25.73, marking a -1.61% move from the previous day.
CoDiagnostics, Inc. (CODX) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CoDiagnostics, Inc. (CODX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CoDiagnostics, Inc. (CODX) closed at $22.12, marking a +1.37% move from the previous day.
Advanced Micro Devices, Under Armour, Immunomedics, GenMark and Co-Diagnostics highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Advanced Micro Devices, Under Armour, Immunomedics, GenMark and Co-Diagnostics highlighted as Zacks Bull and Bear of the Day